Search This Blog

Tuesday, December 31, 2019

China approves sales of first domestically developed pneumonia vaccine

China has approved a pneumonia vaccine developed by domestic drugmaker Walvax Biotechnology, its National Medical Products Administration said in a notice on Tuesday, offering an alternative to Pfizer’s market-dominating Prevnar 13.
Walvax’s pneumococcal 13-valent conjugate vaccine will be mainly used to immunize children from six weeks through to five years of age from the invasive disease caused by 13 types of bacteria, the notice showed.
With more than 15 million newborn babies in 2018, China has huge demand for vaccines targeting pneumonia, which is the major cause of death of children under the age of five, the authority said.
Pfizer’s Prevnar 13, which was approved in China in 2016, was the only pneumococcal 13-valent conjugate vaccine available around the world before Walvax’s product, the notice said.

Chinese officials investigate cause of pneumonia outbreak in Wuhan

Chinese health authorities said they are investigating 27 cases of viral pneumonia in the central city of Wuhan, after rumors on social media suggested the outbreak could be linked to Severe Acute Respiratory Syndrome (SARS).
Of the people infected, seven were in critical condition and 18 were in stable condition, the Wuhan Municipal Health Commission said on Tuesday on its Weibo social media account. The condition of two other patients had improved to the point where they would be discharged soon, it said.
“The cause of the disease is not clear,” the official People’s Daily newspaper said on Weibo, citing unnamed hospital officials. “We cannot confirm it is what’s being spread online, that it is SARS virus. Other severe pneumonia is more likely.”
All of the patients had been isolated and their close contacts are under medical observation, the Wuhan Municipal Health Commission said. An investigation and cleanup were under way at a seafood market in the city, which is suspected to be connected with the cases, it said.
Initial laboratory tests showed that the cases were viral pneumonia. No obvious human-to-human transmission had been found and no medical staff had been infected, the commission said.
A team of experts from the National Health Commission is in Wuhan to carry out tests, state broadcaster CCTV said.
An official at Wuhan Central Hospital, where local media said some of the cases are being treated, declined to comment when contacted by Reuters.

In 2003, Chinese officials covered up a SARS outbreak for weeks before a growing death toll and rumors forced the government to reveal the epidemic, apologize and vow full candor in future outbreaks.
The disease, which emerged in southern China in late 2002, spread rapidly from south China to other cities and countries in 2003. More than 8,000 people were infected and 775 died.

Where jobs were in 2010s

HEALTH AND FITNESS
What Americans do for a living has changed a lot in the last 10 years.
Many old-school industries saw minimal job growth, like manufacturing, or extended declines, like department stores.
The evolving needs of an increasingly technology-oriented economy drove rapid growth in many IT jobs, while an aging population was behind a surge in the number of home health workers. Americans’ changing spending habits – increasingly on experiences over things – helped make fitness center jobs among the fastest growing of the decade.

Homeless man turns Manhattan Whole Foods into his personal hot bar

Bum appétit!
A drooling and pungent homeless man made double-dipping look like child’s play at a Midtown Whole Foods, grabbing from the hot food bar with his bare hands to stuff his bearded face — as employees just chuckled and said they were powerless to stop him.
A Post photo editor had just plunked down $17 for a jerk chicken dinner at the store across from Bryant Park Sunday night when he spotted the grungy gourmand ignoring numerous “no sampling” signs to treat the bar like his personal feed-bag.
The unidentified chowhound pounded mac-and-cheese and mixed veggies, at times using serving spoons to pack multiple dishes into a plastic cup he’d brought with him from the outside.
But at other points, he simply dug in with his visibly-dirty mitts, grabbing food from the trays and shoving it directly into his mouth, wet with drool and framed by a scraggly beard.
In the closest thing to a display of personal hygiene from the man, he stopped every now and then to lick his fingers clean.
All the while, Whole Foods workers looked on, smiling and laughing — while doing nothing to stop the pig-out.
“Oh, he comes here all the time,” said one employee of the freeloader. “We can’t do anything about it, we were told.”
Whole Food Market
Workers on Monday clarified that whenever they see any hot-bar binging they’re supposed to tip off the store’s security guards to step in.
As for the tainted food, workers said that they promptly toss it.
“I just throw out the tray, that’s our routine,” said one store supervisor, who declined to be identified. “We address the situation and throw the tray out and put a fresh one in the bar.”
But the suddenly unsavory meals weren’t tossed by the time The Post left the store on Sunday — and some less-than-appetized customers there on Monday weren’t interested in taking any chances.
“That’s a lot of germs,” said Ronald Cozart, 31. “I won’t be eating here in the future.”
Added one shopper who gave his name as Jay, “Ew. That’s pretty awful. If someone’s hands are in the salad bar and the staff is laughing, I don’t want to waste my money here.”
A man who identified himself as the store’s manager — declining to give his name, despite wearing a tag on the uniform that gave it away as Yoichi — referred requests for comment to the chain’s corporate office.
A message left with that office was not returned.

Monday, December 30, 2019

More Chinese scientists in America are going back home

A growing number of Chinese scientists working in the United States and other parts of the world are returning to their homeland, enhancing China’s research productivity.
In a new study, researchers found that more than 16,000 researchers have returned to China from other countries since that nation has opened up to international engagement. More than 4,500 left the United States for China in 2017 – nearly double the number who left in 2010.
These foreign-trained researchers are helping grow China into a scientific powerhouse, said Caroline Wagner, co-author of the study and associate professor in the John Glenn College of Public Affairs at The Ohio State University.
“In our lifetime, China has joined the global scientific community to become world-class in a number of critical fields, such as AI and materials science,” Wagner said.
“As more of their researchers return home, that rise is going to continue.”
The study was published online this month in the journal Science and Public Policy.
For the study, the researchers made use of a scientific publisher’s (Elsevier) database that allowed them to track researchers based on their publications in scientific journals.
The study’s authors traced the paths of Chinese authors who first published in China and then subsequently in a different country, or, first published abroad and then in China, to track individual mobility.
Results showed that the number of Chinese researchers going to the United States is larger than the number going to Europe. Chinese scientists are more likely to return to their home from Europe than from the United States.
“The most elite Chinese scientists are more likely to stay in the United States than go home – and that’s good for the United States,” Wagner said.
“But increasingly, we found that people are going back. The U.S. has been lucky that many top scientists have stayed. But China has programs to attract them back to their homeland.”
The study showed the returning scientists’ value to China.
Overall, Wagner and her colleagues found that 12 percent of studies published by researchers in China were by those who had worked in other countries – and that is probably an underestimation, she said.
More importantly, those who worked abroad and returned to China published more high-impact research than scientists who didn’t work abroad, according to the study.
“Once they go home, those who worked elsewhere are more productive at the international level than people who stayed in China,” she said.
One reason for the success of the mobile researchers was that they published more studies with foreign-based collaborators. In previous research, Wagner has found that the more open a country is to cross-country scientific cooperation, the stronger its scientific impact.
That’s also one reason why China is fine with the fact that many of its scientists stay in the United States, Europe or elsewhere.
“Chinese leaders value the connections. It is a way to create linkages with the worldwide scientific community,” she said.
A variety of indicators suggest that China’s science and technology capabilities are on a sharply rising trajectory. For one, China’s spending on research and development as tracked by the Organisation for Economic Co-operation and Development has increased faster than overall economic growth in the country.
And by one measure, China ranked second in the world in the number of papers published in indexed scientific journals in 2017.
Wagner said that returning scientists have helped build China’s scientific community, which in turns attracts more of the country’s scientists to come back home. But she said it is still in America’s best interest to try to retain as many of China’s best scholars as possible, and be welcoming to those who visit.
“The U.S. has retained its dynamism in science and technology because excellent scientists from other countries come here,” she said.
“If we lose that attraction, if we discourage people from coming here, it will take a toll on the U.S. scientific system.”
###
Co-authors on the study were Cong Cao of the University of Nottingham Ningbo China; Jeroen Baas of Elsevier and its International Center for the Study of Research in The Netherlands; and Koen Jonkers of the Joint Research Centre, European Commission, in Belgium.

Stryker target upped to $236 from $228 by BTIG

Maintains Buy

Boston Scientific target raised to $52 from $47 by Cowen

Maintain Outperform